Hair cortisol and cortisone measurements for the diagnosis of overt and mild Cushing's syndrome
Abstract
Objective: Hair cortisol (HF) and cortisone (HE) measurements reflect tissular exposure to cortisol over months and are increased in overt Cushing’s syndrome (CS). No data is available in mild CS. We compared the diagnostic performance of HF and HE between patients with overt or mild CS. Design: Single centre retrospective study. Methods: HF&HE were measured by LC-MS/MS in 48 consecutive adult females with Cushing’s disease (CD), ectopic ACTH syndrome, secreting adenomas and carcinomas, and adrenal incidentalomas. All had impaired dexamethasone suppression tests. Overt CS ( n = 25) was diagnosed in front of specific symptoms, a mean UFC (>1.5 ULN) and increased midnight serum cortisol or salivary cortisol. Mild CS ( n = 23) was diagnosed in patients lacking specific symptoms and displaying at least one additional biological abnormality including mildly increased UFC (≤1.5 ULN), increased midnight serum cortisol or salivary cortisol and suppressed plasma ACTH in patients with adrenal tumours. In this study, 84 healthy subjects and obese patients served as controls. Results: HF and HE showed roughly similar performance in overt CS (92 and 100% sensitivity, 91 and 99% specificity, respectively). HF and HE were lower in mild CS but higher than in controls ( P < 0.01). HE was correlated with midnight serum cortisol ( P < 0.02) and volume of adrenal incidentalomas ( P < 0.04) but not with UFC. HF and HE had 59% and 68% sensitivity, and 79 and 94% specificity, respectively, for the diagnosis of mild CS. Contrary to UFC, both HF and HE were in the range of overt CS in 11/23 patients with mild CS. Patients with mild CS and increased HE required more antihypertensive treatments and showed worser lipid profiles than patients with normal HE. Conclusions: HF and HE measurement performed better in overt than in mild CS but is a useful adjunct to diagnose mild CS and to identify adrenocortical incidentalomas responsible for excessive cortisol exposure.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Hair cortisol and cortisone measurements can distinguish CS from controls.
“Overall, hair cortisol and cortisone measurements can distinguish CS from controls, but substantial variability in reported cutoffs and diagnostic performance underscores the lack of validated thresholds and the need for further standardization before routine clinical use.”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [120]
Hair analysis can be performed at any time of the day in an outpatient setting.
“Hair analysis (typically 3 cm closest to the scalp) provides a stable measure of cortisol, reducing false-positive results from acute stressors associated with serum, saliva, or urine testing, and it can be performed at any time of the day in an outpatient setting (120).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [120]
Hair analysis (typically 3 cm closest to the scalp) provides a stable measure of cortisol, reducing false-positive results from acute stressors associated with serum, saliva, or urine testing.
“Hair analysis (typically 3 cm closest to the scalp) provides a stable measure of cortisol, reducing false-positive results from acute stressors associated with serum, saliva, or urine testing, and it can be performed at any time of the day in an outpatient setting (120).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [120]
Substantial variability in reported cutoffs and diagnostic performance of hair cortisol and cortisone underscores the lack of validated thresholds.
“Overall, hair cortisol and cortisone measurements can distinguish CS from controls, but substantial variability in reported cutoffs and diagnostic performance underscores the lack of validated thresholds and the need for further standardization before routine clinical use.”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [120]
Studies evaluating hair cortisol and cortisone have reported diagnostic cutoffs ranging from approximately 5-31 pg/mg for hair cortisol and 14-28 pg/mg for hair cortisone, with sensitivities of ∼60-100% and specificities of ∼79-99%, depending on assay methodology, study population, and disease severity.
“Studies evaluating hair cortisol and cortisone have reported diagnostic cutoffs ranging from approximately 5-31 pg/mg for hair cortisol and 14-28 pg/mg for hair cortisone, with sensitivities of ∼60-100% and specificities of ∼79-99%, depending on assay methodology, study population, and disease severity (Table 3) (119-121).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [120]
Hair cortisol has been shown to differentiate between CS patients and healthy controls with high sensitivity and specificity.
“Hair cortisol has been shown to differentiate between CS patients and healthy controls with high sensitivity and specificity (48, 66).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [66]
Hair steroid analysis has high diagnostic efficacy in screening of CS.
“We and others also showed high diagnostic efficacy in screening of CS with hair steroid analysis.”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [66]
Hair cortisol and cortisone have been shown to contribute to the identification of patients with mild or subclinical CS.
“In addition, hair cortisol and cortisone have been shown to contribute to the identification of patients with mild or subclinical CS (66).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [66]
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · see citing works
Localization of 11 beta-hydroxysteroid dehydrogenase type II in human epithelial tissues.
Smith, R. E., Maguire, J. A., Stein-Oakley, A. N., Sasano, H., Takahashi, K., Fukushima, K., & Krozowski, Z. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784076 · Cited by 146 · see citing works
Kidambi, S., Raff, H., & Findling, J. W. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0424 · Cited by 129 · see citing works
Nunes, M.-L., Vattaut, S., Corcuff, J.-B., Rault, A., Loiseau, H., Gatta, B., Valli, N., Letenneur, L., & Tabarin, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1542 · Cited by 129 · see citing works
Self-citationMasserini, B., Morelli, V., Bergamaschi, S., Ermetici, F., Eller-Vainicher, C., Barbieri, A. M., Maffini, M. A., Scillitani, A., Ambrosi, B., Beck-Peccoz, P., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0485 · Cited by 106 · see citing works
Accuracy of laboratory tests for the diagnosis of Cushing syndrome
Galm, B. P., Qiao, N., Klibanski, A., Biller, B. M. K., & Tritos, N. A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa105 · Cited by 100 · see citing works
Elias, P. C. L., Martinez, E. Z., Barone, B. F. C., Mermejo, L. M., Castro, M., & Moreira, A. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4262 · Cited by 90 · see citing works
Raff, H., & Phillips, J. M. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00186 · Cited by 53 · see citing works
Kannankeril, J., Carroll, T., Findling, J. W., Javorsky, B., Gunsolus, I. L., Phillips, J., & Raff, H. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa107 · Cited by 36 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Approach to the Patient: Diagnosis of Cushing Syndrome
Savas, M., Mehta, S., Agrawal, N., van Rossum, E. F. C., & Feelders, R. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac492 · Cited by 91 · see citing works
“In addition, hair cortisol and cortisone have been shown to contribute to the identification of patients with mild or subclinical CS (66).”
BackgroundMethodTabarin, A., Assié, G., Barat, P., Bonnet, F., Bonneville, J. F., Borson-Chazot, F., Bouligand, J., Boulin, A., Brue, T., Caron, P., et al. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.02.001 · Cited by 59 · see citing works
Nieman, L. K., Castinetti, F., Newell-Price, J. D. C., Valassi, E., Drouin, J., Takahashi, Y., & Lacroix, A. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00588-w · Cited by 73 · see citing works
“143 .”
Botia, M., Escribano, D., Martı́nez-Subiela, S., Tvarijonaviciute, A., Tecles, F., López-Arjona, M., & Cerón, J. M. C. (2023) · Metabolites · doi:10.3390/metabo13010106 · Cited by 37 · see citing works
Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing’s Syndrome
Nieman, L. K. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab046 · Cited by 33 · see citing works
Mechanism, diagnosis, and treatment of cyclic Cushing’s syndrome: A review
Cai, Y., Ren, L., Tan, S.-W., Liu, X., Li, C., Gang, X., & Wang, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113301 · Cited by 31 · see citing works
Emerging diagnostic methods and imaging modalities in cushing’s syndrome
Wright, K. E., van Rossum, E. F. C., Zan, E., Werner, N. L., Harris, A. G., Feelders, R. A., & Agrawal, N. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1230447 · Cited by 25 · see citing works
“Hair glucocorticoid measurements are performed with either immunoassay (35, 40) or liquid chromatography tandem mass spectrometry (LC-MS/MS) (18, 39).”
BackgroundMethodFerrière, A., & Tabarin, A. (2021) · La Presse Médicale · doi:10.1016/j.lpm.2021.104091 · Cited by 19 · see citing works
Self-citationFlowers, K. C., & Shipman, K. E. (2023) · Diagnostics · doi:10.3390/diagnostics13081415 · Cited by 16 · see citing works
“Hair cortisone may improve diagnostic efficiency; however, hair cortisol and cortisone may miss cases in mild Cushing syndrome phenotypes [93,94].”
BackgroundPuglisi, S., Leporati, M., Amante, E., Parisi, A., Pia, A. R., Berchialla, P., Terzolo, M., Vincenti, M., & Reimondo, G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.833514 · Cited by 10 · see citing works
“This finding is in line with previous studies and may be explained with the presence in the scalp of the 11b-hydroxysteroid dehydrogenase type 2 enzyme (23, 24).”
BackgroundResultInfluentialAbrial, E., Chalancon, B., Leaune, É., Brunelin, J., Wallon, M., Moll, F., Barakat, N., Hoestlandt, B., Fourier, A., Simon, L., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.916640 · Cited by 6 · see citing works
“In collaboration with University Hospital of Bordeaux, assays will be performed by Liquid Chromatography with tandem mass spectrometry as previously detailed in the study of Brossaud and colleagues (2021) (39).”
MethodHeyns, B., Pieters, R., Stander, M. A., Atkin, S. L., & Swart, A. C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1448013 · Cited by 4 · see citing works
The Determination of Endogenous Steroids in Hair and Fur: A Systematic Review of Methodologies.
Maher, P., Healy, M., Laird, E., Karšaj, J. M., Gao, W., & Zgaga, L. (2024) · Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106649 · Cited by 4 · see citing works
What is hair cortisol analysis and how can it aid endocrinologists?
Kirschbaum, C. (2024) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2024.2365786 · Cited by 6 · see citing works
“HE may eventually turn out to be even more sensitive and specific than HF levels as indicated in a recent study of patients with mild Cushing’s disease [14].”
Mytareli, C., Athanasouli, F., Andreadaki, E., Thanasoula, F., & Angelousi, A. (2023) · HORMONES · doi:10.1007/s42000-023-00495-x · Cited by 3 · see citing works
“The data regarding the diagnostic role of hair F analysis for the diagnosis of milder hypercortisolemia cases are limited and tend to be conflicting [19, 24].”
Hamidi, O., St-Jean, M., Lacroix, A., & Bancos, I. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag095 · Cited by 5 · see citing works
Deryol, H. Y., Tek, S., Akpinar, E., Erkan, B., Keskin, Ü., Tuna, M. M., Niyazoğlu, M., & Hatipoğlu, E. (2026) · HORMONES · doi:10.1007/s42000-025-00750-3 · Cited by 2 · see citing works
“These values are consistent with previ - ously published data, where Brossaud et al. reported sensitivity of 93% and specificity of 87% using a similar HCC threshold [ 6 ].”
InfluentialCurrent challenges in Cushing's syndrome testing: blood, saliva, urine, or hair?
Ferrière, A., & Tabarin, A. (2025) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000923 · Cited by 2 · see citing works
Self-citationMACS: mild by definition, challenging by nature
Bluszcz, G., Roszkowska, Z., Domański, J., Sharabi, A., Rapiejko, J., Malek, J., Ambroziak, U., & Bobrowicz, M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1957127
A challenging diagnosis of pediatric (cyclic) Cushing disease: the decisive role of hair cortisol
Berkenbosch, L., & Straetemans, S. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag195
“Given the average hair growth rate of approximately 1 cm per month, segmental analysis of scalp hair can provide a retrospective timeline of cortisol exposure over several months [2, 8].”
Measurement of Hair Cortisol Throughout Gestation
Estrada, J., Miglino, M., Ponce-Rojas, N., & del Sol, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15083052
“Finally, although the use of mass spectrometry for cortisol detection is predominantly reported in the literature [27,48], in this study the chemiluminescence technique was chosen using the Maglumi 800 equipment, considering its greater availability in healthcare and research centers, and also…”
Lefèvre, C. R., Vaduva, P., Kvasnička, A., Lenski, M., Senarathne, U. D., Taie, S. F., Zibar, K., & Rolić, T. (2026) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2026-0101
“For example, cortisol and cortisone concentrations in hair samples are a valuable tool in assessing long-term glucocorticoids exposure and detect hypo-and hypercortisolism [37, 38], and salivary cortisol and cortisone are now widely spread biomarkers of Cushing ’ s syndrome [39].”
Tabarin, A., & Nunès, M. (2022) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(22)44261-2
Self-citationResearch Progress in Diagnostic Methods of Cushing’s Syndrome
郭, 林. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1662449
- Authors
- Brossaud, J., Charret, L., De Angeli, D., Haissaguerre, M., Ferriere, A., Puerto, M., Gatta-Cherifi, B., Corcuff, J.-B., & Tabarin, A.
- Affiliations
- Université de Bordeaux (FR)
- 4Department of Radiology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
- 3Department of Endocrinology, Diabetes and Nutrition, CHU of Bordeaux and University of Bordeaux, France
- Corresponding author
- Tabarin, Antoine
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-03
- Volume
- 184
- Issue
- 3
- Pages
- 445-454
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W3125813855
- Cited by
- 29
- References
- 0
- Citations by year
- 2026: 7 · 2025: 3 · 2024: 6 · 2023: 6 · 2022: 5 · 2021: 2
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- hair cortisol, hair cortisone, Cushing's syndrome, Cushing's disease, ectopic ACTH syndrome, adrenal incidentaloma, urinary free cortisol, sensitivity and specificity, antihypertensive therapy, lipid profile
- MeSH terms
- ACTH Syndrome, Ectopic, Adenoma, Adrenal Gland Neoplasms, Adult, Aged, Cortisone, Cushing Syndrome, Diagnostic Techniques, Endocrine, Female, Hair, Humans, Hydrocortisone, Middle Aged, Predictive Value of Tests, Retrospective Studies, Sensitivity and Specificity, Severity of Illness Index, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review